http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005533084-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
filingDate 2003-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2005533084-A
titleOfInvention Oral dosage form comprising a liquid active ingredient formulation and controlled release by an swellable osmotic composition
abstract The present invention provides a controlled release oral dosage form for delivery of a liquid active ingredient formulation. The dosage form of the present invention includes a reservoir molded from an impermeable material and filled with a liquid active ingredient formulation. The dosage form of the present invention also includes an inflatable osmotic composition disposed within the reservoir, and in some cases, the inflatable osmotic composition is substantially impervious to fluid passage. A barrier layer that is permeable separates the liquid active ingredient from contact with the formulation. In order to facilitate the discharge of the liquid active ingredient formulation, the dosage form of the present invention also includes an exit orifice. The composition and design of the reservoir material encompassed by the dosage form of the present invention is the production of an oral dosage form that can achieve the desired release rate or release rate profile of the active ingredient from a liquid formulation more consistently. Enable.
priorityDate 2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 42.